Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HRS-4729 in Type 2 Diabetes
NCT07843862Phase 2Not yet recruiting
- Sponsor
- Fujian Shengdi Pharmaceuticals
- Start
- Oct 2026
- Primary completion
- Apr 2027
- Countries
- 1
01
Overview
A Phase 2 trial of HRS-4729 in type 2 diabetes mellitus (T2DM), sponsored by Fujian Shengdi Pharmaceuticals. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
HRS-4729
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT07843862.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07843862.